Advertisement

Topics

Sage Therapeutics postpartum depression drug meets main goal

06:14 EST 9 Nov 2017 | Reuters

(Reuters) - Sage Therapeutics on Thursday said it's drug to treat moderate and severe postpartum depression met the main goal in two late-stage studies.

Original Article: Sage Therapeutics postpartum depression drug meets main goal

NEXT ARTICLE

More From BioPortfolio on "Sage Therapeutics postpartum depression drug meets main goal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...